Oragenics Inc
OGEN· NYSE
OGENOragenics Inc
Filed Feb 28, 2014 · 10-K · 59 days after period end · 0001193125-14-077374
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $434.78K | $430.58K | $396.59K | — |
| Net Income | -$3.08M | -$1.99M | -$1.94M | — |
| EPS Diluted | -$0.09 | -$0.07 | -$0.33 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Feb 28, 2014 · 59 d after period end
